NCT05937386View on ClinicalTrials.gov

Drug-Drug Interaction Study With AGMB-129 and Midazolam in Healthy Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

14

Participants

Timeline

Start Date

August 9, 2023

Primary Completion Date

September 6, 2023

Study Completion Date

September 6, 2023

Conditions

Healthy Volunteers

Interventions

DRUG

AGMB-129

Oral capsule

DRUG

MDZ

Pre-filled oral syringes

Trial Locations (1)

Unknown

SGS Belgium, Edegem

All Listed Sponsors

lead

Agomab Spain S.L.

INDUSTRY